March 28, 2020: LGP is the first & still only company producing locally grown (Australia) cannabis products with the GMP manufacturing method. Their facility is now capable of producing up to 110,000 bottles of medicinal cannabis oil per year, ten times more than before.
“We have signed sales agreements into some of the world’s largest medicinal cannabis markets, including Germany and the UK, and this expanded facility represents a major milestone in enhancing our ability to improve the lives of patients in Australia and overseas.” - LGP Managing Director
March 27, 2020: LGP upgrade of their cultivation facility’s expansion is complete. They are capable of meeting international medicinal cannabis product demand with their 110,000 bottle of cannabis oil (per annum) manufacturing ability.
March 23, 2020: Little Green Pharma answers questions around where medicinal cannabis products come. They state that all their medicinal marijuana products are made in Australia.
@LittleGreenPHAR UPDATE: Please be assured that our dedication to the ongoing supply of #australianmade products to our patients is an absolute priority. If you have questions or issues, please feel free to contact us on: Ph: 1300 118 840 OR Email: email@example.com pic.twitter.com/X1hOSLEJj2
commenced trading on 20th of February 2020 under the code “ASX.LGP”
They raised the maximum subscription for their IPO of $10 million
They have dispensed over 7,600 medicinal cannabis oil (CBD and THC) since 2018
Over 2,300 patients subscribing to medicinal cannabis from LGP
The funds raised through LGP’s IPO is to follow their growth strategy that includes: funding a manufacturing site, furthering Western Australian research and development in medicinal cannabis, expanding on sales and marketing to secure more distribution channels internationally.
Perth-based medicinal cannabis company @LittleGreenPHAR (ASX: $LGP) – which recently listed on the ASX – has entered a deal to supply the full suite of its medicinal cannabis products to UK-based Astral Health.https://t.co/Kshdsbv6HC
January 13, 2020:Curtin University partners with Little Green Pharma. LGP will provide medicinal cannabis products to be used for research and trials.
“it was an exciting opportunity for Little Green Pharma, as Australia’s first locally grown medicinal cannabis producer, to partner with Curtin University on a genuinely innovative drug delivery technology.” said Dr Leon Warne, Head of Research & Innovation at LGP
James is an experienced writer and legal cannabis advocate in Australia. He answers all the questions about business, legalisation and medicinal cannabis.
Disclaimer: Cannabis Place are not doctors and we recommend consulting health professionals for accurate information. This site may contain information regarding drugs. This content is designed for an 18+ audience. Click here for our full disclaimer
Tasmanian Botanics is a family-owned and runs cannabis cultivation, production and research company. Their focus is to utilise Tasmania's clean environment and their modern cultivation facility to produce medical-grade cannabis for Australian and international distribution.
TasCann is a Tasmanian cannabis medical supplier for dry herb and hybrid medical marijuana plants. Breeding medical-grade cannabis plants from Landrace strains to produce the highest quality weed plants in Australia.